The architectural details of a notorious cancer-promoting protein offer clues about how to keep it safely switched off.
All in National Cancer Institute
The architectural details of a notorious cancer-promoting protein offer clues about how to keep it safely switched off.
Recurrence of breast cancer metastases in the brain was low among women who received an experimental drug combination in a phase I clinical trial.
The cloudy thinking caused by some chemotherapies may be due to Interruptions to DNA repair in the brain.
A new approach allows researchers to investigate cells’ mechanical properties in tissue-like environments.
Tumor-promoting signals are elevated in lung tumor cells with high bacterial burdens.
Scientists have assembled a library of immune receptors that direct T cells to target cells with mutations in p53, the most commonly mutated gene in human cancers.
Machine learning model predicts T cells’ tumor response.
Evaluating T-cell resilience can help researchers predict—and possibly improve—the outcomes of cancer immunotherapy.
Not all small cell lung cancers are the same.